Statins, bone metabolism and treatment of bone catabolic diseases

Yijia Zhang, Aaron D. Bradley, Dong Wang, Richard A Reinhardt

Research output: Contribution to journalReview article

38 Citations (Scopus)

Abstract

The discovery that statins had bone anabolic properties initiated many investigations into their use for treatment of bone catabolic diseases, such as osteoporosis. This paper reviews the molecular basis of statin's role in bone metabolism, and animal and human studies on the impact of systemic statins on osteoporosis-induced bone fracture incidence and healing, and on bone density. Limitations of systemic statins are described along with alternative dosing strategies, including local applications and bone-targeting systemic preparations. The principal findings of this review are: (1) traditional oral dosing with statins results in minimal efficacy in the treatment of osteoporosis; (2) local applications of statins show promise in the treatment of accessible bony defects, such as periodontitis; and (3) systemically administered statins which can target bone or inflammation near bone may be the safest and most effective strategy in the treatment of osseous deficiencies.

Original languageEnglish (US)
Pages (from-to)53-61
Number of pages9
JournalPharmacological Research
Volume88
DOIs
StatePublished - Aug 19 2014

Fingerprint

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Bone Diseases
Bone and Bones
Osteoporosis
Osteitis
Fracture Healing
Periodontitis
Bone Fractures
Bone Density
Incidence

Keywords

  • Bone fracture
  • Bone metabolism
  • Osteoporosis
  • Periodontitis
  • Statins

ASJC Scopus subject areas

  • Pharmacology

Cite this

Statins, bone metabolism and treatment of bone catabolic diseases. / Zhang, Yijia; Bradley, Aaron D.; Wang, Dong; Reinhardt, Richard A.

In: Pharmacological Research, Vol. 88, 19.08.2014, p. 53-61.

Research output: Contribution to journalReview article

@article{40bf1a827ef5442998cea472f349e668,
title = "Statins, bone metabolism and treatment of bone catabolic diseases",
abstract = "The discovery that statins had bone anabolic properties initiated many investigations into their use for treatment of bone catabolic diseases, such as osteoporosis. This paper reviews the molecular basis of statin's role in bone metabolism, and animal and human studies on the impact of systemic statins on osteoporosis-induced bone fracture incidence and healing, and on bone density. Limitations of systemic statins are described along with alternative dosing strategies, including local applications and bone-targeting systemic preparations. The principal findings of this review are: (1) traditional oral dosing with statins results in minimal efficacy in the treatment of osteoporosis; (2) local applications of statins show promise in the treatment of accessible bony defects, such as periodontitis; and (3) systemically administered statins which can target bone or inflammation near bone may be the safest and most effective strategy in the treatment of osseous deficiencies.",
keywords = "Bone fracture, Bone metabolism, Osteoporosis, Periodontitis, Statins",
author = "Yijia Zhang and Bradley, {Aaron D.} and Dong Wang and Reinhardt, {Richard A}",
year = "2014",
month = "8",
day = "19",
doi = "10.1016/j.phrs.2013.12.009",
language = "English (US)",
volume = "88",
pages = "53--61",
journal = "Pharmacological Research",
issn = "1043-6618",
publisher = "Academic Press Inc.",

}

TY - JOUR

T1 - Statins, bone metabolism and treatment of bone catabolic diseases

AU - Zhang, Yijia

AU - Bradley, Aaron D.

AU - Wang, Dong

AU - Reinhardt, Richard A

PY - 2014/8/19

Y1 - 2014/8/19

N2 - The discovery that statins had bone anabolic properties initiated many investigations into their use for treatment of bone catabolic diseases, such as osteoporosis. This paper reviews the molecular basis of statin's role in bone metabolism, and animal and human studies on the impact of systemic statins on osteoporosis-induced bone fracture incidence and healing, and on bone density. Limitations of systemic statins are described along with alternative dosing strategies, including local applications and bone-targeting systemic preparations. The principal findings of this review are: (1) traditional oral dosing with statins results in minimal efficacy in the treatment of osteoporosis; (2) local applications of statins show promise in the treatment of accessible bony defects, such as periodontitis; and (3) systemically administered statins which can target bone or inflammation near bone may be the safest and most effective strategy in the treatment of osseous deficiencies.

AB - The discovery that statins had bone anabolic properties initiated many investigations into their use for treatment of bone catabolic diseases, such as osteoporosis. This paper reviews the molecular basis of statin's role in bone metabolism, and animal and human studies on the impact of systemic statins on osteoporosis-induced bone fracture incidence and healing, and on bone density. Limitations of systemic statins are described along with alternative dosing strategies, including local applications and bone-targeting systemic preparations. The principal findings of this review are: (1) traditional oral dosing with statins results in minimal efficacy in the treatment of osteoporosis; (2) local applications of statins show promise in the treatment of accessible bony defects, such as periodontitis; and (3) systemically administered statins which can target bone or inflammation near bone may be the safest and most effective strategy in the treatment of osseous deficiencies.

KW - Bone fracture

KW - Bone metabolism

KW - Osteoporosis

KW - Periodontitis

KW - Statins

UR - http://www.scopus.com/inward/record.url?scp=84906791607&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84906791607&partnerID=8YFLogxK

U2 - 10.1016/j.phrs.2013.12.009

DO - 10.1016/j.phrs.2013.12.009

M3 - Review article

VL - 88

SP - 53

EP - 61

JO - Pharmacological Research

JF - Pharmacological Research

SN - 1043-6618

ER -